Jia Yu

2.8k total citations
55 papers, 1.5k citations indexed

About

Jia Yu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jia Yu has authored 55 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 23 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Jia Yu's work include DNA Repair Mechanisms (9 papers), Ubiquitin and proteasome pathways (7 papers) and Cancer-related Molecular Pathways (6 papers). Jia Yu is often cited by papers focused on DNA Repair Mechanisms (9 papers), Ubiquitin and proteasome pathways (7 papers) and Cancer-related Molecular Pathways (6 papers). Jia Yu collaborates with scholars based in United States, China and United Kingdom. Jia Yu's co-authors include Liewei Wang, Bo Qin, Zhenkun Lou, Somaira Nowsheen, Xinyi Tu, Jian Yuan, Richard M. Weinshilboum, Judy C. Boughey, Matthew P. Goetz and Fei Zhao and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Jia Yu

54 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jia Yu United States	20	930	556	270	182	149	55	1.5k
Ying Cao United States	23	1.2k 1.3×	402 0.7×	306 1.1×	123 0.7×	169 1.1×	48	1.7k
Laura Tamblyn Canada	16	999 1.1×	496 0.9×	250 0.9×	352 1.9×	91 0.6×	22	1.6k
Shing Leng Chan Singapore	22	977 1.1×	375 0.7×	258 1.0×	143 0.8×	104 0.7×	33	1.4k
Fátima Valdés‐Mora Australia	19	975 1.0×	415 0.7×	277 1.0×	334 1.8×	128 0.9×	31	1.5k
Wengeng Zhang China	20	773 0.8×	482 0.9×	224 0.8×	116 0.6×	187 1.3×	46	1.4k
Girieca Lorusso Switzerland	19	603 0.6×	553 1.0×	271 1.0×	304 1.7×	126 0.8×	25	1.3k
Pengfei Shi China	9	956 1.0×	656 1.2×	460 1.7×	169 0.9×	166 1.1×	15	1.5k
Shiv K. Gupta United States	24	1.1k 1.2×	483 0.9×	292 1.1×	148 0.8×	176 1.2×	56	1.7k
Lingfeng He China	24	1.4k 1.5×	465 0.8×	439 1.6×	165 0.9×	279 1.9×	60	1.9k

Countries citing papers authored by Jia Yu

Since Specialization

Citations

This map shows the geographic impact of Jia Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jia Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jia Yu more than expected).

Fields of papers citing papers by Jia Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jia Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jia Yu. The network helps show where Jia Yu may publish in the future.

Co-authorship network of co-authors of Jia Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Jia Yu. A scholar is included among the top collaborators of Jia Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jia Yu. Jia Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yu, Jia, et al.. (2023). USP10 Regulates ZEB1 Ubiquitination and Protein Stability to Inhibit ZEB1-Mediated Colorectal Cancer Metastasis. Molecular Cancer Research. 21(6). 578–590. 15 indexed citations

Yu, Jia, Yongxian Zhuang, Xiaoyang Fan, et al.. (2022). Identification of Src Family Kinases as Potential Therapeutic Targets for Chemotherapy-Resistant Triple Negative Breast Cancer. Cancers. 14(17). 4220–4220. 11 indexed citations

Wei, Lixuan, Huanyao Gao, Jia Yu, et al.. (2022). Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor–Positive Breast Cancer. Cancer Research. 83(3). 456–470. 17 indexed citations

Nguyen, Thanh Thanh L., Duan Liu, Huanyao Gao, et al.. (2022). Glucocorticoids mediate transcriptome‐wide alternative polyadenylation: Potential mechanistic and clinical implications. Clinical and Translational Science. 15(11). 2758–2771. 1 indexed citations

Nguyen, Thanh Thanh L., Huanyao Gao, Duan Liu, et al.. (2022). Glucocorticoids unmask silent non-coding genetic risk variants for common diseases. Nucleic Acids Research. 50(20). 11635–11653. 6 indexed citations

Yu, Jia, et al.. (2022). Privacy-Preserving and Verifiable Outsourcing Message Transmission and Authentication Protocol in IoT. 556–564. 1 indexed citations

Boughey, Judy C., Vera J. Suman, Jia Yu, et al.. (2021). Patient-Derived Xenograft Engraftment and Breast Cancer Outcomes in a Prospective Neoadjuvant Study (BEAUTY). Clinical Cancer Research. 27(17). 4696–4699. 13 indexed citations

Zhuang, Yongxian, Peter T. Vedell, Jia Yu, et al.. (2021). Establishment and characterization of immortalized human breast cancer cell lines from breast cancer patient-derived xenografts (PDX). npj Breast Cancer. 7(1). 79–79. 7 indexed citations

Yu, Jia, Bo Qin, Ann M. Moyer, et al.. (2020). Regulation of sister chromatid cohesion by nuclear PD-L1. Cell Research. 30(7). 590–601. 71 indexed citations

10.

Qin, Bo, Jia Yu, Somaira Nowsheen, et al.. (2020). STK38 promotes ATM activation by acting as a reader of histone H4 ufmylation. Science Advances. 6(23). eaax8214–eaax8214. 44 indexed citations

11.

Shee, Kevin, Matthew Ung, Nicole A. Traphagen, et al.. (2019). A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 Inhibition. Clinical Cancer Research. 26(1). 159–170. 1 indexed citations

12.

Yu, Jia, Chao Ma, Guoping Dong, et al.. (2019). The effector of Hippo signaling, Taz, is required for formation of the micropyle and fertilization in zebrafish. PLoS Genetics. 15(1). e1007408–e1007408. 15 indexed citations

13.

Kalari, Krishna R., Jason P. Sinnwell, Kevin J. Thompson, et al.. (2018). PANOPLY: Omics-Guided Drug Prioritization Method Tailored to an Individual Patient. JCO Clinical Cancer Informatics. 2(2). 1–11. 11 indexed citations

14.

Tu, Xinyi, Mohamed M. Kahila, Qin Zhou, et al.. (2018). ATR Inhibition Is a Promising Radiosensitizing Strategy for Triple-Negative Breast Cancer. Molecular Cancer Therapeutics. 17(11). 2462–2472. 71 indexed citations

15.

Yu, Jia, Chao Ma, Li Li, et al.. (2018). Yap1/Taz are essential for the liver development in zebrafish. Biochemical and Biophysical Research Communications. 503(1). 131–137. 12 indexed citations

16.

Kurmi, Kiran, Jia Yu, Felix Boakye‐Agyeman, et al.. (2018). Tyrosine Phosphorylation of Mitochondrial Creatine Kinase 1 Enhances a Druggable Tumor Energy Shuttle Pathway. Cell Metabolism. 28(6). 833–847.e8. 47 indexed citations

17.

Qin, Sisi, Duan Liu, Manish Kohli, et al.. (2017). TSPYL Family Regulates CYP17A1 and CYP3A4 Expression: Potential Mechanism Contributing to Abiraterone Response in Metastatic Castration‐Resistant Prostate Cancer. Clinical Pharmacology & Therapeutics. 104(1). 201–210. 29 indexed citations

18.

Qin, Sisi, James N. Ingle, Mohan Liu, et al.. (2017). Calmodulin-like protein 3 is an estrogen receptor alpha coregulator for gene expression and drug response in a SNP, estrogen, and SERM-dependent fashion. Breast Cancer Research. 19(1). 95–95. 23 indexed citations

19.

Liu, Tongzheng, Yuan Fang, Haoxing Zhang, et al.. (2015). HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy. Cancer Research. 76(3). 572–581. 33 indexed citations

20.

Qin, Bo, Katherine Minter‐Dykhouse, Jia Yu, et al.. (2015). DBC1 Functions as a Tumor Suppressor by Regulating p53 Stability. Cell Reports. 10(8). 1324–1334. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact